Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenotype-Guided Vasoactive Protocol in Kidney Transplant
NCT07633600Phase 4Enrolling by invitation
- Start
- Jun 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of vasopressin, norepinephrine, calcium chloride and dopamine in kidney transplantation. Primary endpoint: Positive Flow-Pressure Coupling Proportion in Hyperdynamic Phenotype. Started Jun 2026; status: enrolling by invitation.
02
Drugs
vasopressinnorepinephrinecalcium chloridedopamine
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT07633600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07633600.